FGF21 and metabolic dysfunction-associated steatotic liver disease: Together, there is compelling evidence for FGF21 to improve insulin sensitivity in MASLD patients through different mechanisms, and we observed highly significant correlations between FGF21 and genes coding for energy sensing (Figure S4A).